Ashley Sanford
Adult Health · Tylertown, MSNPI 1326511031
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations.
Across 106 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$325
- AstraZeneca$311
- Amgen$290
- AbbVie$255
- Novo Nordisk$223
- Tris Pharma Inc$127
- plus $694 from 17 others
What the payments were for
- Food & beverage$2,225100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $325 |
| AstraZeneca | 10 | $311 |
| Amgen | 7 | $290 |
| AbbVie | 15 | $255 |
| Novo Nordisk | 12 | $223 |
| Tris Pharma Inc | 8 | $127 |
| Pfizer | 6 | $107 |
| Lilly USA, LLC | 6 | $95 |
| GSK | 5 | $87 |
| Baxter Healthcare | 2 | $55 |
| Exact Sciences | 2 | $48 |
| Abbott | 2 | $47 |
| IBSA Pharma Inc. | 2 | $34 |
| Novartis | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Boehringer Ingelheim | 2 | $31 |
| Dynavax Technologies Corporation | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Bayer | 1 | $15 |
How this compares
$2,225 in reported general payments places this provider in the 75th percentile of 93 adult health providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 32 | $33,222 |
| OzempicSemaglutide | 23 | $32,411 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $21,733 |
| MounjaroTirzepatide | 11 | $12,337 |
| EliquisApixaban | 12 | $9,633 |
| Repatha SureclickEvolocumab | 14 | $7,413 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $759 |
| Losartan Potassium | 106 | $694 |
| SynthroidLevothyroxine Sodium | 11 | $691 |
| Irbesartan | 52 | $684 |
| Fluticasone Propionate | 55 | $652 |
| Atorvastatin Calcium | 90 | $537 |
| Rosuvastatin Calcium | 98 | $518 |
| Gabapentin | 74 | $504 |
| Duloxetine Hcl | 24 | $489 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $31 | $33,22232 claims |
| Novo NordiskOzempic | $223 | $32,41123 claims |
| GSKTrelegy Ellipta | $87 | $21,73323 claims |
| Lilly USA, LLCMounjaro | $95 | $12,33711 claims |
| PfizerEliquis | $107 | $9,63312 claims |
| AbbVieSynthroid | $255 | $69111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 93 adult health providers in Mississippi.
Other adult health in Tylertown
- Amanda GreeneRidgeland$108K
- Rhonda HickmanTupelo$15K
- Angela SlaterFlorence$14K
- Jennifer Delaney-DavisOcean Springs$9K
- Traci EvansGulfport$8K
- Casey AdamsGulfport$8K
- Keila BrownJackson$7K
- Brandi JohnstonJackson$7K
- Elizabeth WhiteHattiesburg$6K
- Jessica JonesHattiesburg$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.